Published in J Virol on May 01, 1999
Biochemical analysis of distinct activation functions in p300 that enhance transcription initiation with chromatin templates. Mol Cell Biol (1999) 2.80
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16. Proc Natl Acad Sci U S A (2012) 1.88
Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes. J Virol (2008) 1.53
p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol Cell Biol (2001) 1.34
Structural basis for subversion of cellular control mechanisms by the adenoviral E1A oncoprotein. Proc Natl Acad Sci U S A (2009) 1.31
A role for coactivators and histone acetylation in estrogen receptor alpha-mediated transcription initiation. EMBO J (2001) 1.25
Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet (2009) 1.07
Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53. J Virol (2006) 1.07
The E6 protein of the cutaneous human papillomavirus type 8 can stimulate the viral early and late promoters by distinct mechanisms. J Virol (2006) 0.94
The SV40 T antigen modulates CBP histone acetyltransferase activity. Nucleic Acids Res (2003) 0.94
The critical protein interactions and structures that elicit growth deregulation in cancer and viral replication. Wiley Interdiscip Rev Syst Biol Med (2010) 0.88
Negative regulation of transcription coactivator p300 by orphan receptor TR3. Nucleic Acids Res (2007) 0.83
The HTLV-1-encoded protein HBZ directly inhibits the acetyl transferase activity of p300/CBP. Nucleic Acids Res (2012) 0.83
Involvement of {beta}-catenin and unusual behavior of CBP and p300 in glucocorticosteroid signaling in Schwann cells. Proc Natl Acad Sci U S A (2005) 0.81
The adenoviral E1A protein displaces corepressors and relieves gene repression by unliganded thyroid hormone receptors in vivo. Cell Res (2009) 0.81
Coactivators p300 and PCAF physically and functionally interact with the foamy viral trans-activator. BMC Mol Biol (2004) 0.78
MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Mol Cancer (2007) 0.77
De-acetylation and degradation of HSPA5 is critical for E1A metastasis suppression in breast cancer cells. Oncotarget (2014) 0.77
Interaction of the transactivation domain of B-Myb with the TAZ2 domain of the coactivator p300: molecular features and properties of the complex. PLoS One (2012) 0.76
Competitive Inhibition of Lysine Acetyltransferase 2B by a Small Motif of the Adenoviral Oncoprotein E1A. J Biol Chem (2016) 0.75
Mdm2 promotes the rapid degradation of p53. Nature (1997) 21.26
Regulation of p53 stability by Mdm2. Nature (1997) 18.20
Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell (1997) 16.79
The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell (1992) 16.53
Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (1993) 11.54
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (1996) 10.81
Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature (1994) 9.37
Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev (1994) 8.92
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature (1993) 7.90
Role of CBP/P300 in nuclear receptor signalling. Nature (1996) 7.36
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature (1995) 7.11
Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 6.73
A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell (1993) 6.13
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev (1994) 5.68
Mapping of the p53 and mdm-2 interaction domains. Mol Cell Biol (1993) 5.31
Binding and modulation of p53 by p300/CBP coactivators. Nature (1997) 5.12
Recruitment of p300/CBP in p53-dependent signal pathways. Cell (1997) 5.10
CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A (1997) 4.71
Synergistic activation of transcription by CBP and p53. Nature (1997) 4.54
Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (1995) 4.49
Acetylation of general transcription factors by histone acetyltransferases. Curr Biol (1997) 4.22
RNA helicase A mediates association of CBP with RNA polymerase II. Cell (1997) 4.00
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol (1997) 3.62
Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol Cell Biol (1993) 3.54
Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell (1997) 3.54
CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J (1995) 3.22
Human p300 protein is a coactivator for the transcription factor MyoD. J Biol Chem (1996) 3.05
The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J (1992) 2.97
Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol (1993) 2.92
DNA tumor virus transforming proteins and the cell cycle. Curr Opin Genet Dev (1993) 2.88
Transcription. A growing coactivator network. Nature (1996) 2.71
Abnormal skeletal patterning in embryos lacking a single Cbp allele: a partial similarity with Rubinstein-Taybi syndrome. Proc Natl Acad Sci U S A (1997) 2.68
Conjunction dysfunction: CBP/p300 in human disease. Trends Genet (1998) 2.64
Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci U S A (1997) 2.63
The acetyltransferase activity of CBP stimulates transcription. EMBO J (1998) 2.45
Association of p300 and CBP with simian virus 40 large T antigen. Mol Cell Biol (1996) 2.40
Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr Biol (1997) 2.25
The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res (1993) 2.17
p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J (1997) 2.05
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene (1994) 1.94
Versatile molecular glue. Transcriptional control. Curr Biol (1996) 1.85
Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin. EMBO J (1998) 1.56
Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J (1998) 1.56
The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res (1996) 1.47
Adenovirus E1A downregulates cJun- and JunB-mediated transcription by targeting their coactivator p300. Mol Cell Biol (1996) 1.40
Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene (1997) 1.36
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol (1996) 1.24
Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein. Mol Biol Cell (1992) 1.24
Regulation of MyoD gene transcription and protein function by the transforming domains of the adenovirus E1A oncoprotein. Oncogene (1993) 1.23
Complementary functions of E1a conserved region 1 cooperate with conserved region 3 to activate adenovirus serotype 5 early promoters. J Virol (1994) 1.21
E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J Virol (1995) 1.17
MDM2--arbiter of p53's destruction. Trends Biochem Sci (1997) 1.15
Transcriptional modulation by the adenovirus E1A gene. Curr Top Microbiol Immunol (1995) 1.00
Transcription factors. CREB takes CBP to tango. Nature (1994) 1.00
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature (2001) 19.54
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91
Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature (1998) 8.75
Rb targets histone H3 methylation and HP1 to promoters. Nature (2001) 8.26
Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol (1983) 5.98
Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J (1989) 5.93
HDAC4 deacetylase associates with and represses the MEF2 transcription factor. EMBO J (1999) 5.54
DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat Genet (2000) 5.29
The TAF(II)250 subunit of TFIID has histone acetyltransferase activity. Cell (1996) 5.20
Construction of a fusion gene that confers resistance against hygromycin B to mammalian cells in culture. Exp Cell Res (1985) 4.42
Regulation of E2F1 activity by acetylation. EMBO J (2000) 4.18
Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J (1986) 3.89
Transcriptional activation functions in BRCA2. Nature (1997) 3.86
Cellular and molecular biology of the aquaporin water channels. Annu Rev Biochem (1999) 3.65
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
Aquaporin CHIP: the archetypal molecular water channel. Am J Physiol (1993) 3.41
Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway. Genes Dev (2000) 3.38
Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J Virol (1987) 3.36
Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J (2001) 3.36
Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature (1995) 3.32
Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol (1995) 3.26
CBP-induced stimulation of c-Fos activity is abrogated by E1A. EMBO J (1995) 3.22
Repression of RNA polymerase III transcription by the retinoblastoma protein. Nature (1996) 3.04
Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter. Gene (1979) 3.00
Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci U S A (1998) 2.99
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc Natl Acad Sci U S A (1993) 2.90
Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84
Use of the lambda phage promoter PL to promote gene expression in hybrid plasmid cloning vehicles. Methods Enzymol (1979) 2.74
Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A (1994) 2.72
MEF-2 function is modified by a novel co-repressor, MITR. EMBO J (1999) 2.71
Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene (1995) 2.64
RB and hbrm cooperate to repress the activation functions of E2F1. Proc Natl Acad Sci U S A (1997) 2.53
The acetyltransferase activity of CBP stimulates transcription. EMBO J (1998) 2.45
The co-repressor mSin3A is a functional component of the REST-CoREST repressor complex. J Biol Chem (2000) 2.28
Fault lubrication during earthquakes. Nature (2011) 2.28
Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol (1995) 2.27
Long-term regulation of four renal aquaporins in rats. Am J Physiol (1996) 2.27
Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J (1994) 2.25
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth. EMBO J (1999) 2.23
Rapid gating and anion permeability of an intracellular aquaporin. Nature (1999) 2.17
The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res (1993) 2.17
Map position and nucleotide sequence of the gene for the large structural phosphoprotein of human cytomegalovirus. J Virol (1987) 2.11
Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Müller cells and fibrous astrocytes. J Neurosci (1998) 2.11
Heterotetrameric composition of aquaporin-4 water channels. Biochemistry (1999) 2.05
The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood. J Thromb Haemost (2014) 2.03
The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID. J Virol (1994) 2.01
Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer (2001) 1.99
New cosmid vectors developed for eukaryotic DNA cloning. Gene (1984) 1.97
Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol (1995) 1.96
The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol (1999) 1.94
Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J Virol (1999) 1.92
Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev (1992) 1.90
[Complications of total hip prosthesis]. Arch Orthop Unfallchir (1969) 1.90
Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol (1992) 1.88
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev (1997) 1.85
Progesterone and glucocorticoid response elements occur in the long control regions of several human papillomaviruses involved in anogenital neoplasia. J Virol (1989) 1.83
Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers. Nucleic Acids Res (1990) 1.81
Detection of Duffy antigen in the plasma membranes and caveolae of vascular endothelial and epithelial cells of nonerythroid organs. Blood (1997) 1.79
E1A directly binds and regulates the P/CAF acetyltransferase. EMBO J (1998) 1.76
Transcriptional repression by the insulator protein CTCF involves histone deacetylases. Nucleic Acids Res (2000) 1.74
Retinoblastoma protein meets chromatin. Trends Biochem Sci (1999) 1.72
During negative regulation of the human papillomavirus-16 E6 promoter, the viral E2 protein can displace Sp1 from a proximal promoter element. Nucleic Acids Res (1992) 1.69
The E6/E7 promoter of human papillomavirus type 16 is activated in the absence of E2 proteins by a sequence-aberrant Sp1 distal element. J Virol (1990) 1.68
Bending the primary cilium opens Ca2+-sensitive intermediate-conductance K+ channels in MDCK cells. J Membr Biol (2003) 1.66
Cytomegalovirus encephalitis in patients with acquired immunodeficiency syndrome: an autopsy study of 30 cases and a review of the literature. Hum Pathol (1987) 1.66
Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Mol Cell Biol (2001) 1.65
Redistribution of aquaporin-2 water channels induced by vasopressin in rat kidney inner medullary collecting duct. Am J Physiol (1995) 1.64
Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest (1996) 1.64
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest (1995) 1.63
In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene (1991) 1.63
Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J Natl Cancer Inst (1999) 1.62
Localization and regulation of the rat renal Na(+)-K(+)-2Cl- cotransporter, BSC-1. Am J Physiol (1996) 1.60
An E2F-like repressor of transcription. Nature (1997) 1.59
Viral oncoproteins target the DNA methyltransferases. Oncogene (2006) 1.59
Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. Am J Physiol (1998) 1.59
Clinical follow-up of phototherapeutic keratectomy for treatment of corneal opacities. Am J Ophthalmol (1993) 1.58
Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J Clin Microbiol (1991) 1.57
Health-related quality of life of patients with juvenile idiopathic arthritis coming from 3 different geographic areas. The PRINTO multinational quality of life cohort study. Rheumatology (Oxford) (2006) 1.55
Biphasic changes of epithelial sodium channel abundance and trafficking in common bile duct ligation-induced liver cirrhosis. Kidney Int (2006) 1.54
Acetylation of importin-alpha nuclear import factors by CBP/p300. Curr Biol (2000) 1.54
AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality. Kidney Int (2008) 1.54
Aquaporin-6: An intracellular vesicle water channel protein in renal epithelia. Proc Natl Acad Sci U S A (1999) 1.52
E2F1 and E1A(12S) have a homologous activation domain regulated by RB and CBP. Proc Natl Acad Sci U S A (1996) 1.52
Assessment of bone mineral density in adults with a history of juvenile chronic arthritis: a cross-sectional long-term followup study. Arthritis Rheum (1999) 1.52
Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites. Nucleic Acids Res (1990) 1.51
Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun (2000) 1.50
Arginine vasopressin stimulates phosphorylation of aquaporin-2 in rat renal tissue. Am J Physiol (1999) 1.50
Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function. Nucleic Acids Res (1989) 1.50
Epithelial glycoprotein-330 mediates endocytosis of plasminogen activator-plasminogen activator inhibitor type-1 complexes. J Biol Chem (1993) 1.50
Differential localization of HDAC4 orchestrates muscle differentiation. Nucleic Acids Res (2001) 1.49
Impaired aquaporin and urea transporter expression in rats with adriamycin-induced nephrotic syndrome. Kidney Int (1998) 1.49
The Children's Global Assessment Scale (CGAS) and Global Assessment of Psychosocial Disability (GAPD) in clinical practice--substance and reliability as judged by intraclass correlations. Eur Child Adolesc Psychiatry (2000) 1.49
Photodynamic therapy of malignant tumours. Lancet (1972) 1.48